Overdiagnosis and Overtreatment of Breast Cancer: How Can We Promote Informed Patient Choice? Elissa M. Ozanne Invited Commentary 25 October 2013 Pages: 263 - 265
Biomarkers in Breast Cancer and the Implications of Their Discordance Ashish SinghBhawna SirohiSudeep Gupta Biomarkers (S Dawood, Section Editor) 19 October 2013 Pages: 266 - 274
Biomarkers of Therapeutic Resistance in Breast Cancer Sudeep GuptaAshish SinghBhawna Sirohi Biomarkers (S Dawood, Section Editor) 23 October 2013 Pages: 275 - 283
Breast Cancer Biomarkers: Utility in Clinical Practice Fanny Le DuNaoto T. UenoAna M. Gonzalez-Angulo Biomarkers (S Dawood, Section Editor) 25 October 2013 Pages: 284 - 292
Clinical Trials for Breast Cancer with Brain Metastases: Challenges and New Directions Aki MorikawaKomal JhaveriAndrew D. Seidman Clinical Trials (MN Dickler, Section Editor) 04 October 2013 Pages: 293 - 301
Utility of GnRH-Agonists for Fertility Preservation in Women with Operable Breast Cancer: Is It Protective? Giuliano BedoschiVolkan TuranKutluk Oktay Clinical Trials (MN Dickler, Section Editor) 10 October 2013 Pages: 302 - 308
New Approaches for Hormone-Receptor Positive Metastatic Breast Cancer Eirini ThanopoulouStephen R. D. Johnston Clinical Trials (MN Dickler, Section Editor) 10 October 2013 Pages: 309 - 320
Dual Targeting of Human Epidermal Growth Factor Receptor 2 (HER2) in Neoadjuvant Trials for Operable HER2 Positive (HER2+) Disease Komal JhaveriChau Dang Clinical Trials (MN Dickler, Section Editor) 15 November 2013 Pages: 321 - 330
Novel Therapies for Metastatic HER2 Positive Breast Cancer Rachel Jorge Dino CossettiKaren A. Gelmon Clinical Trials (MN Dickler, Section Editor) 27 September 2013 Pages: 331 - 340